|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Glixis Therapeutics, LLC
| | | Phone: | (818) 633-1244 | Year Established: | 2012 | Main Contact: | Michael Demetriou, M.D. Ph.D., Co-Founder | | Company Description | Glixis Therapeutics is developing a first-of-its-kind compound for progressive Multiple Sclerosis for which no FDA-approved treatment currently exists. Glixis Therapeutics combines a leading candidate drug for progressive MS with a development pipeline including a proprietary diagnostic technology as well as proprietary genetic testing technology for progressive MS. This integrated approach supports significant changes to the current therapeutic landscape for MS and the potential for personalized medicine. | |
|
|
|
|
|